In COVID-19 clinical update #78, Daniel Griffin covers ivermectin, convalescent plasma, disease in pregnant women, children and COVID, delta outbreak in an elementary school, validation of at-home antigen test, shedding in infected vaccinated people, mRNA vaccine antibody responses compared, AZD7442, fluvoxamine, one year outcomes in hospitalized patients, and post-vaccination disease.
每周播报：https://www.microbe.tv/twiv/
推特：https://twitter.com/DanielGriffinMD
问题交流：Send your questions for Dr. Griffin to daniel@microbe.tv
祝平安。
Links for this episode
- Do not take veterinary ivermectin (FDA)
- Ivermectin side effects (CDC)
- Do not use convalescent plasma (IDSA)
- COVID-19 in pregnant women (JAMA)
- Children and COVID-19 data (AAP)
- Long COVID in 11-17 year olds (Res Square)
- Delta outbreak elementary school (MMWR)
- Validation of at-home antigen test (JAMA)
- Shedding in infected vaccinated people (medRxiv)
- Compared antibody responses after mRNA vaccination (JAMA)
- AZD7442 PROVENT phase III (AZ)
- Fluvoxamine trial (medRxiv)
- One-year outcomes hospital survivors (Lancet)
- Post-vaccination illness (Lancet)
- Letters read on TWiV 800
